Special issue on in vitro MN trial

James M Parry1, Micheline Kirsch-Volders

  • 1School of Medicine, University of Wales-Swansea, Swansea, United Kingdom.

Mutation Research
|July 27, 2010
PubMed

Insights

This commentary discusses the in vitro micronucleus (MN) test, focusing on its predictivity for in vivo assays. Optimizing cell line choice and protocols enhances its reliability for genotoxicity testing.

Area of Science:

  • Toxicology
  • Genotoxicity Testing
  • In Vitro Assays

Background:

  • The in vitro micronucleus (MN) test is a key assay for genotoxicity assessment.
  • Understanding factors influencing its reliability is crucial for toxicological relevance.
  • Predictive accuracy for in vivo outcomes remains an area for refinement.

Purpose of the Study:

  • To provide additional insights into the in vitro MN test.
  • To evaluate the test's predictivity for in vivo MN assays.
  • To explore how cell line selection and protocol variations impact test sensitivity and reliability.

Main Methods:

  • Commentary based on existing knowledge and considerations.
  • Analysis of factors influencing in vitro MN test outcomes.
  • Discussion on the role of cytochalasin-B in the protocol.

Main Results:

  • The choice of cell line and specific protocol (e.g., with or without cytochalasin-B) significantly influences the in vitro MN test's sensitivity and predictivity.
  • These factors are critical for interpreting results and ensuring toxicological relevance.
  • Optimized protocols can improve the test's ability to detect both clastogenic and aneugenic events.

Conclusions:

  • The in vitro MN test can be a reliable and sensitive genotoxicity assay.
  • Careful consideration of cell line and protocol is essential for accurate prediction of in vivo genotoxicity.
  • This approach supports the assessment of genotoxic risk in humans.

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...